Stericycle, Inc. (NASDAQ:SRCL) – Equities researchers at Northcoast Research dropped their Q3 2017 earnings per share estimates for Stericycle in a research note issued on Friday. Northcoast Research analyst E. Snyder now forecasts that the business services provider will post earnings per share of $1.13 for the quarter, down from their previous estimate of $1.17. Northcoast Research also issued estimates for Stericycle’s Q4 2017 earnings at $1.20 EPS, FY2017 earnings at $4.57 EPS, Q1 2018 earnings at $1.24 EPS, Q2 2018 earnings at $1.07 EPS, Q3 2018 earnings at $1.17 EPS and Q4 2018 earnings at $1.23 EPS.
SRCL has been the subject of several other research reports. BidaskClub upgraded Stericycle from a “strong sell” rating to a “sell” rating in a research report on Monday, July 24th. Jefferies Group LLC set a $108.00 price objective on Stericycle and gave the company a “buy” rating in a research report on Thursday, August 3rd. Robert W. Baird downgraded Stericycle from a “neutral” rating to an “underperform” rating and lowered their price objective for the company from $74.00 to $73.00 in a research report on Monday, May 15th. Deutsche Bank AG decreased their target price on Stericycle from $14.00 to $10.00 and set a “buy” rating for the company in a report on Monday, May 15th. Finally, BMO Capital Markets began coverage on Stericycle in a report on Thursday, June 29th. They set a “market perform” rating and a $81.00 target price for the company. Four equities research analysts have rated the stock with a sell rating, six have issued a hold rating and six have given a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average target price of $81.15.
ILLEGAL ACTIVITY WARNING: This piece was posted by Rincon Hill News and is owned by of Rincon Hill News. If you are reading this piece on another website, it was copied illegally and reposted in violation of United States & international copyright and trademark legislation. The original version of this piece can be read at https://rinconhillneighbors.org/2017/08/19/stericycle-inc-nasdaqsrcl-to-post-q3-2017-earnings-of-1-13-per-share-northcoast-research-forecasts-updated.html.
Stericycle (NASDAQ:SRCL) opened at 77.06 on Monday. The company has a 50-day moving average of $76.90 and a 200-day moving average of $80.64. The company has a market cap of $6.57 billion, a price-to-earnings ratio of 40.16 and a beta of 0.13. Stericycle has a one year low of $71.52 and a one year high of $90.43.
Stericycle (NASDAQ:SRCL) last issued its quarterly earnings data on Thursday, August 3rd. The business services provider reported $1.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.13 by $0.02. The business had revenue of $917.70 million during the quarter, compared to analyst estimates of $902.81 million. Stericycle had a negative net margin of 0.07% and a positive return on equity of 14.35%. The firm’s quarterly revenue was up 2.9% on a year-over-year basis. During the same quarter last year, the business earned $1.18 EPS.
A number of institutional investors have recently bought and sold shares of SRCL. RiverPoint Capital Management LLC increased its position in Stericycle by 0.6% in the second quarter. RiverPoint Capital Management LLC now owns 5,152 shares of the business services provider’s stock worth $393,000 after buying an additional 29 shares during the period. HighTower Advisors LLC increased its position in Stericycle by 0.5% in the first quarter. HighTower Advisors LLC now owns 7,604 shares of the business services provider’s stock worth $627,000 after buying an additional 41 shares during the period. Morgan Dempsey Capital Management LLC increased its position in Stericycle by 2.6% in the first quarter. Morgan Dempsey Capital Management LLC now owns 1,902 shares of the business services provider’s stock worth $158,000 after buying an additional 48 shares during the period. Pacer Advisors Inc. increased its position in Stericycle by 3.3% in the first quarter. Pacer Advisors Inc. now owns 1,735 shares of the business services provider’s stock worth $144,000 after buying an additional 55 shares during the period. Finally, OppenheimerFunds Inc. increased its position in Stericycle by 1.2% in the first quarter. OppenheimerFunds Inc. now owns 5,266 shares of the business services provider’s stock worth $436,000 after buying an additional 60 shares during the period. Institutional investors and hedge funds own 95.16% of the company’s stock.
Stericycle Company Profile
Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.
Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with our FREE daily email newsletter.